Deletion of pancreatic -cell adenosine kinase improves glucose homeostasis in young mice and ameliorates streptozotocin-induced hyperglycaemia.
- Additional Document Info
- View All
Severe reduction in the -cell number (collectively known as the -cell mass) contributes to the development of both type 1 and type 2 diabetes. Recent pharmacological studies have suggested that increased pancreatic -cell proliferation could be due to specific inhibition of adenosine kinase (ADK). However, genetic evidence for the function of pancreatic -cell ADK under physiological conditions or in a pathological context is still lacking. In this study, we crossed mice carrying LoxP-flanked Adk gene with Ins2-Cre mice to acquire pancreatic -cell ADK deficiency (Ins2-Cre Adkfl/fl ) mice. Our results revealed that Ins2-Cre+/- Adkfl/fl mice showed improved glucose metabolism and -cell mass in younger mice, but showed normal activity in adult mice. Moreover, Ins2-Cre Adkfl/fl mice were more resistant to streptozotocin (STZ) induced hyperglycaemia and pancreatic -cell damage in adult mice. In conclusion, we found that ADK negatively regulates -cell replication in young mice as well as under pathological conditions, such as STZ induced pancreatic -cell damage. Our study provided genetic evidence that specific inhibition of pancreatic -cell ADK has potential for anti-diabetic therapy.
author list (cited authors)
Ahmed Abdalhamid Osman, M., Sun, Y., Li, R., Lin, H., Zeng, D., Chen, X., ... Yu, X.
complete list of authors
Ahmed Abdalhamid Osman, Makawi||Sun, Yu-Jing||Li, Rui-Jia||Lin, Hui||Zeng, Dong-Mei||Chen, Xin-Yu||He, Dongfang||Feng, Hui-Wei||Yang, Zhao||Wang, Jin||Wu, Chaodong||Cui, Min||Sun, Jin-Peng||Huo, Yuqing||Yu, Xiao